New hope for tough prostate cancer: drug combo trial launches
NCT ID NCT07206056
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 31 times
Summary
This study tests a new combination of two drugs (tulmimetostat and JSB462) against standard care in men with advanced prostate cancer that has spread and no longer responds to hormone therapy. The trial has two parts: first finding the safest dose, then comparing the combo's effectiveness. About 188 men will take part worldwide.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROGRESSIVE METASTATIC CASTRATE RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fred Hutchinson Cancer Research Center
RECRUITINGSeattle, Washington, 98109-1024, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mass General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Email: •••••@•••••
Contact
-
Novartis Investigative Site
RECRUITINGSt Leonards, New South Wales, 2065, Australia
-
Novartis Investigative Site
RECRUITINGMelbourne, Victoria, 3000, Australia
-
Novartis Investigative Site
RECRUITINGLiverpool, 2170, Australia
-
Novartis Investigative Site
RECRUITINGHalifax, Nova Scotia, B3H 2Y9, Canada
-
Novartis Investigative Site
RECRUITINGBeijing, 100021, China
-
Novartis Investigative Site
RECRUITINGHerlev, DK-2730, Denmark
-
Novartis Investigative Site
RECRUITINGOdense C, 5000, Denmark
-
Novartis Investigative Site
RECRUITINGVejle, DK-7100, Denmark
-
Novartis Investigative Site
RECRUITINGBordeaux, 33076, France
-
Novartis Investigative Site
RECRUITINGParis, 75015, France
-
Novartis Investigative Site
RECRUITINGParis, 75231, France
-
Novartis Investigative Site
RECRUITINGDüsseldorf, North Rhine-Westphalia, 40225, Germany
-
Novartis Investigative Site
RECRUITINGMilan, MI, 20133, Italy
-
Novartis Investigative Site
RECRUITINGPadova, PD, 35128, Italy
-
Novartis Investigative Site
RECRUITINGOrbassano, TO, 10043, Italy
-
Novartis Investigative Site
RECRUITINGKuching, Sarawak, 93586, Malaysia
-
Novartis Investigative Site
RECRUITINGPoznan, 60-192, Poland
-
Novartis Investigative Site
RECRUITINGSingapore, 119074, Singapore
-
Novartis Investigative Site
RECRUITINGSingapore, S308433, Singapore
-
Novartis Investigative Site
RECRUITINGSantiago Compostela, A Coruna, 15706, Spain
-
Novartis Investigative Site
RECRUITINGL'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28009, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28041, Spain
-
Novartis Investigative Site
RECRUITINGSutton, Surrey, SM2 5PT, United Kingdom
-
Novartis Investigative Site
RECRUITINGLondon, W1G 6AD, United Kingdom
-
Sarah Cannon Research Institute
RECRUITINGDenver, Colorado, 80218, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sarah Cannon Research Institute
RECRUITINGJacksonville, Florida, 32256, United States
Contact Email: •••••@•••••
Contact
-
Wichita Urology Group PA
RECRUITINGWichita, Kansas, 67226, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.